- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06372691
How Do We Ultrasound-Guided Popliteal Approach Sciatic Nerve Block?
How Do We Ultrasound-Guided Popliteal Approach Sciatic Nerve Block;Is It Injection Subparaneural, Interneural?
Study Overview
Status
Intervention / Treatment
Detailed Description
The study will involve American Society of Anesthesiologists Physical Status Classification (ASA) III or IV risk group patients, 18 years of age or older, who will undergoing foot, ankle, or toe amputation.
Supparaneural injection (Group S) and interneural injection method (Group I) will the two research groups to which patients were randomly allocated.
Every 5 minutes following LA injection, an investigator who will blind to randomization will assess the sensory and motor blockage in the operated foot. The study will documented the operative time, block characteristics, such as the duration of block administration, sensory and motor block start and regression times, the time of extra analgesic required, and the occurrence of complications.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey, 06000
- Ankara Bilkent City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years and over
- Planned foot, ankle or toe amputation
- ASA III-IV risk group
- Patients who agreed to be included in the study
Exclusion Criteria:
- People with neurological and psychiatric diseases
- Using opioids or another analgesic for chronic pain
- Allergic to local anesthetics
- Pregnant or breastfeeding
- Those with infection or sepsis in the application area
- Patients who did not agree to be included in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Subparaneural Injection (Group S)
The position of the patients will be prone.The skin will be cleaned according to asepsis and antisepsis rules.After preparing the USG a high-frequency linear array transducer under sterile conditions,we will be positioned it transversely in the popliteal fossa.After visualizing the artery,its hyperechoic nerves will be founded superficially.The sciatic nerve will be identified proximally to visualize where the TN and CPN eventually come together to form the sciatic nerve and separate distally where the CPN moves laterally and the TN remains medially.Once the nerves began to separate,they will be scanned until a figure 8 or pant leg image will be obtained.Using the in-plane technique under ultrasonography guidance, injection will be applied to the subparaneural area in Group S.1 ml of LA solution was injected for the purpose of verifying proper needle insertion.A standard dose of 15 mL bupivacaine 0.5% and 5mg/mL local anesthetic was used accompanied by a 20G,12mm block needle.
|
Comparison of two different methods in terms of various features
|
|
Active Comparator: Interneural Injection (Group I)
The position of the patients will be prone.The skin will be cleaned according to asepsis and antisepsis rules.After preparing the USG a high-frequency linear array transducer under sterile conditions, we will be positioned it transversely in the popliteal fossa.After visualizing the artery, its hyperechoic nerves will be founded superficially.The sciatic nerve will be identified proximally to visualize where the TN and CPN eventually come together to form the sciatic nerve and separate distally where the CPN moves laterally and the TN remains medially.Once the nerves began to separate, they will be scanned until a figure 8 or pant leg image will be obtained.Using the in-plane technique under ultrasonography guidance, injection will be applied to the interneural area in Group I.1 ml of LA solution was injected for the purpose of verifying proper needle insertion.A standard dose of 15 mL bupivacaine 0.5% and 5mg/mL local anesthetic was used accompanied by a 20 G, 12mm block needle.
|
Comparison of two different methods in terms of various features
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Onset Time
Time Frame: Time from the moment the block is made to the moment it starts, within the first half hour
|
Onset time will be defined as the moment when it is determined that the block is successful.
|
Time from the moment the block is made to the moment it starts, within the first half hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Block Execution Times
Time Frame: 1-10 minutes
|
The time from the moment the block starts to the moment the transaction ends.
|
1-10 minutes
|
|
Need for Multiple Injections Owing to Insufficient Anesthesia
Time Frame: Within 24 hours
|
How many blocks should be made.
|
Within 24 hours
|
|
Additional Rescue Analgesic
Time Frame: Within 24 hours
|
Analgesic use status.
|
Within 24 hours
|
|
Adverse Effects to Anesthesia
Time Frame: During the block period, within 24 hours
|
hypotension, agitation, nausea, vomiting, dizziness
|
During the block period, within 24 hours
|
|
Hemodynamic Effects Of The Block
Time Frame: 0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
|
Noninvasive systolic and diastolic blood pressure
|
0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
|
|
Effects Of The Block On Heart Rate
Time Frame: 0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
|
Heart rate
|
0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
|
|
Effects Of The Block On Peripheral Pulse Oximetry
Time Frame: 0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
|
Peripheral pulse oximetry
|
0th minutes, 5th minutes,10th minutes,15th minutes,20th minutes,25th minutes,30th minutes,35th minutes,40th minutes,45th minutes,50th minutes,55th minutes and 60th minutes and then at 1-hour intervals and 15th minutes,30th minutes
|
|
Regression Time Of Sensory and Motor Block
Time Frame: Within 24 hours
|
When the block starts to come back.
|
Within 24 hours
|
|
Total Block Times
Time Frame: Within 24 hours
|
How long the block took in total.
|
Within 24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Semih Başkan, Ankara City Hospital Bilkent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PoplitealApproach SciaticBlock
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Regional Anesthesia Morbidity
-
Cairo UniversityRecruiting
-
Ain Shams UniversityRecruitingRegional Anesthesia MorbidityEgypt
-
Assiut UniversityNot yet recruitingRegional Anesthesia Morbidity
-
Sanliurfa Education and Research HospitalCompleted
-
Boston Children's HospitalWithdrawnRegional Anesthesia MorbidityUnited States
-
Baylor College of MedicineWithdrawnRegional Anesthesia MorbidityUnited States
-
Onur SelviCompleted
-
Duke UniversityCompletedRegional Anesthesia MorbidityUnited States
-
Koç UniversityCompletedRegional Anesthesia MorbidityTurkey (Türkiye)
-
Sivas State HospitalCompletedRegional Anesthesia MorbidityTurkey
Clinical Trials on Subparaneural Injection (Grup S), Block
-
University of ParmaCompletedPostoperative Pain | Orthopedic Surgical ProceduresItaly
-
University of ParmaCompletedFoot Diseases | Injuries, Knee | Orthopedic Disorders | Injuries, Leg | Injuries, FootItaly
-
Assiut UniversityCompletedPain, PostoperativeEgypt
-
Gulhane School of MedicineCompletedDiabetic Foot | Wound Heal | Regional Anesthesia | Catheter BlockageTurkey
-
Ankara Etlik City HospitalEnrolling by invitationTotal Knee Arthroplasty for GonarthrosisTurkey (Türkiye)
-
Derince Training and Research HospitalCompletedAnesthesia, RegionalTurkey
-
Diskapi Teaching and Research HospitalCompleted
-
Ain Shams UniversityNot yet recruitingFunctional Recovery | Adductor Canal Block | Total Knee Replacement Surgery
-
Cairo UniversityUnknownRegional Anesthesia MorbidityEgypt
-
Rutgers UniversityCompletedTrigger Point Pain, Myofascial | Nerve Block | Myofascial Pain - Dysfunction Syndrome of TMJ